BETTER THE BOSTON AND ROME ALTERNATIVES.
1. IF YOU HAVE SEVERE PSORIASIS you are at increased risk of cardiovascular complications.
2. According to Dr. Denise L Faustman, see faustmanlab.org, it is best to increase the level of TNF alpha rather than decrease same.
3 I am a (human) MONKEY WITH TYPE 1 DIABETES AND PLAQUE PSORIASIS.
4. I have found that plaque psoriasis responds to BCG vaccinations.
5. Rather than pay your cardiologist to kill you I will pay you to (kill me) AND demonstrate on You Tube that injections of BCG treats plaque psoriasis.
You will find ample scientific publications to support the use of BCG .See eg pubmed.org
Robati RM, Partovi-Kia M, Haghighatkhah HR, Younespour S, Abdollahimajd F.
J Am Acad Dermatol. 2014 Jul 16. pii: S0190-9622(14)01567-9. doi: 10.1016/j.jaad.2014.06.006. [Epub ahead of print]
- PMID:
- 25043845
- [PubMed - as supplied by publisher]
2.
Torres T, Bettencourt N, Ferreira J, Carvalho C, Mendonça D, Pinho-Costa P, Vasconcelos C, Selores M, Silva B.
Br J Dermatol. 2014 Jul 17. doi: 10.1111/bjd.13271. [Epub ahead of print]
- PMID:
- 25040543
- [PubMed - as supplied by publisher]
3.
Dominguez AR, Condie D.
J Am Acad Dermatol. 2014 Aug;71(2):388-9. doi: 10.1016/j.jaad.2014.02.048. No abstract available.
- PMID:
- 25037785
- [PubMed - in process]
Related citations
PUTTING THE US HEALTHCARE SYSTEM TO SHAME. SUPPORT ITALY.
PUTTING THE US HEALTHCARE SYSTEM TO SHAME. SUPPORT ITALY.
Ristori
G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P,
Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M,
Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti
M.
Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4.
- PMID:
- 24306002
- [PubMed - indexed for MEDLINE]
Related citations
Faustman DL, Davis M.
Front Immunol. 2013 Dec 23;4:478. doi: 10.3389/fimmu.2013.00478.
- PMID:
- 24391650
- [PubMed]
Related citations
Result Filters
Cell Mol Life Sci. 2005 Aug;62(16):1850-62.
The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis.
Abstract
Excess levels of tumor necrosis factor-alpha (TNF-alpha) have been associated with certain autoimmune diseases. Under the rationale that elevated TNF-alpha levels are deleterious, several anti-TNF-alpha therapies are now available to block the action of TNF-alpha in patients with autoimmune diseases with a chronic inflammatory component to the destructive process. TNF-alpha
antagonists have provided clinical benefit to many patients, but their
use also is accompanied by new or aggravated forms of autoimmunity. Here
we propose a mechanistically based hypothesis for the adverse events
observed with TNF-alpha antagonists, and argue for the opposite therapeutic strategy: to boost or restore TNF-alpha
activity as a treatment for some forms of autoimmunity. Activation
defects in the transcription factor nuclear factor kappaB leave
autoreactive T cells sensitive to TNF-alpha-induced apoptosis. Treatment with TNF-alpha,
by destroying autoreactive T cells, appears to be a highly targeted
strategy to interrupt the pathogenesis of type 1 diabetes, lupus and
certain forms of autoimmunity.
- PMID:
- 15968469
- [PubMed - indexed for MEDLINE]
No comments:
Post a Comment